Page (1) of 1 - 07/11/14
Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy
July 11, 2014 --
Our Apologies, This article is no longer available, You may have followed an outdated link.
Canada, USA, Inc., Medicine, Disease, medical technologists, Surgery, Medication, Science, Internet Technology, Medical,
All Rights Reserved